Ascend Wellness Holdings, Inc. (OTC:AAWH - Free Report) - Stock analysts at Ventum Cap Mkts issued their Q4 2024 earnings estimates for shares of Ascend Wellness in a note issued to investors on Tuesday, November 12th. Ventum Cap Mkts analyst A. Semple anticipates that the company will post earnings per share of ($0.07) for the quarter. The consensus estimate for Ascend Wellness' current full-year earnings is ($0.32) per share. Ventum Cap Mkts also issued estimates for Ascend Wellness' FY2025 earnings at ($0.26) EPS and FY2026 earnings at ($0.18) EPS.
Ascend Wellness (OTC:AAWH - Get Free Report) last announced its earnings results on Tuesday, November 12th. The company reported ($0.13) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.03). The company had revenue of $141.65 million during the quarter, compared to analysts' expectations of $144.13 million. Ascend Wellness had a negative net margin of 15.47% and a negative return on equity of 72.18%.
Ascend Wellness Price Performance
Shares of AAWH traded down $0.03 during mid-day trading on Friday, hitting $0.47. The company's stock had a trading volume of 691,410 shares, compared to its average volume of 221,432. The firm has a 50-day simple moving average of $0.82 and a 200 day simple moving average of $0.95. The firm has a market capitalization of $99.66 million, a P/E ratio of -1.13 and a beta of 1.69. The company has a current ratio of 1.47, a quick ratio of 1.29 and a debt-to-equity ratio of 2.61. Ascend Wellness has a 1-year low of $0.42 and a 1-year high of $1.82.
About Ascend Wellness
(
Get Free Report)
Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands.
Read More
Before you consider Ascend Wellness, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ascend Wellness wasn't on the list.
While Ascend Wellness currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
